07.01.2013 Views

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

LPAWS<br />

89005<br />

High: >60 mg/dL<br />

LDL CHOLESTEROL<br />

Optimal: or =190 mg/dL<br />

NON HDL CHOLESTEROL<br />

Desirable: or =190 mg/dL<br />

The National Cholesterol Education Program (NCEP) and National Health and Nutrition Examination<br />

Survey (NHANES) has set the following guidelines for lipids (total cholesterol, triglycerides, HDL, and<br />

LDL cholesterol) in children ages 2-17:<br />

TOTAL CHOLESTEROL<br />

Desirable: or =200 mg/dL<br />

TRIGLYCERIDES<br />

Normal: or =130 mg/dL<br />

HDL CHOLESTEROL<br />

Low HDL: or =60 mg/dL<br />

LDL CHOLESTEROL<br />

Desirable: or =130 mg/dL<br />

Clinical References: See individual unit codes<br />

Lipoprotein (a) Cholesterol, Serum<br />

Clinical Information: Lipoprotein (a) (Lp[a]) is a highly heterogeneous molecule, consisting of a<br />

low-density lipoprotein (LDL) with a highly glycosylated apolipoprotein(a) (apo[a]) covalently linked<br />

to the apolipoprotein B moiety of LDL via a single disulfate bond. Lp(a) has been associated with<br />

atherogenesis and promotion of thrombosis. Increased levels of Lp(a) have been estimated to confer a<br />

1.5 to 3.0-fold increased risk for coronary artery disease (CAD) in many but not all studies. Apo(a) has<br />

approximately 80% structural homology with plasminogen, but does not contain the active site for fibrin<br />

cleavage. One proposed mechanism for Lp(a)â€s atherogenicity is competition for binding sites with<br />

plasminogen during fibrin clot formation and the resulting inhibition of fibrinolysis. Recently a high<br />

correlation was demonstrated between Lp(a) and oxidized LDL, suggesting that the atherogenicity of<br />

Lp(a) lipoprotein may be mediated in part by associated proinflammatory oxidized phospholipids. Lack<br />

of standardization of assays and apo(a) heterogeneity may partially account for these discrepancies. The<br />

heterogeneity of Lp(a) arises mainly from the variable number of kringle repeats in the apo(a) portion of<br />

the molecule. Kringles are specific structural domains containing 3 intra-strand disulfide bonds that are<br />

highly homologous to similar repeats found in plasminogen. In the clinical laboratory, immunologic<br />

methods are generally used to quantify Lp(a) protein mass. Reagents for Lp(a) mass measurement are<br />

Current as of January 3, 2013 2:22 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong>Laboratories.com Page 1119

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!